Epstein Secrets

2019 13:10 Provider: Beaudouin, Robert MD Reg #: 76318-054 Facility: NYM Unit: Z05 Chronic Care - 14 Day Physician Eval encounter performed at Health Services. SUBJECTIVE: COMPLAINT 1 Provider: Beaudouin. Robert MD Chief Complaint: ENDO/LIPID Subjective: 66 YR OL HYPERT 800 MEDS HX OF O MACHINE.

uma Date/Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YEAR

ity: NYM Note Date: 07/24/2019 151 0 Provider: Beaudouin, Robert MD Unit: H01 Admin Note - General Administrative Note encounter performed at Health Services. Administrative Notes: ADMINISTRATIVE NOTE 1 Provider: Beaudouin, Robert MD PATIENT WAS OFFERED TO HAVE AN OPTOMETRIST EVALUATION. HE REFUSED. RE

ervices. SUBJECTIVE: COMPLAINT 1 Provider: Beaudouin, Robert MD Chief Complaint: ENDO/LIPID Subjective: 66 YR OL HITE MALE WITH HX OF HYPERT CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS 800 , . STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE MEDS • EIR GI SIDE EFFECTS. HX OF

te: 07/30/2019 15:58 Provider M Race: WHITE Reg #: 76318-054 Facility: NYM Unit: Z01 Chronic Care Chronic Care Clinic encounter performed at Health Services. SUBJECTIVE: COMPLAINT 1 Provider: Chief Complaint: Other Problem Subjective: PATIENT WAS REFERRED BY THE WARDEN FOR EVALUATION. PATIENT REPOR

uma Date Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YEAR

ne or more rooms designated specifically for housing an inmate on suicide watch. These areas are set aside as special cells, typically in the BOP's Health Services division, which allow staff to maintain a safe environment for the inmate without compromising the ability to observe and protect the inmate. This e

TIVE: COMPLAINT 1 Provider: f b}CS); (b)(?)(C) IMO Chief Complaint: ENDO/LIPID Unit: 205 Subjective: 66 YR OL~ITE MALE WITH HX OF HYPERT ~ CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS 800, ~:1 . STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE MEDS blc{iilR GI SIDE EFFECTS. HX

nter Date: 07/12/2019 13:10 Provider: Reg #: 76318.054 Facility: NYM MD Unit: Z05 Chronic Care - 14 Day Physician Eval encounter performed at Health Services. SUBJECTIVE: COMPLAINT 1 Provider: Chief Complaint: ENDO/LIPID Subjective: 66 YR OL HYPERT 800 . MEDS HX OF O MACHINE. STATES THE L4 - L

Date/Year: Injury: Mechanism: Onset: Duration: Exacerbating Factors: Relieving Factors: Reason Not Done: Comments: MD HITE MALE WITH HX OF CERIDEMIA X 5 YEARS ON VASCEPA FOR 1 YEAR. STATES TRIGL WAS STATES HE COULD NOT TOLERATE OTHER ANTI-TRIGLYCERIDE EIR GI SIDE EFFECTS. UVE SLEEP APNEA X 5 YEAR